Mouse models of nesprin-related diseases

被引:11
|
作者
Zhou, Can [1 ,2 ]
Rao, Li [1 ]
Warren, Derek T. [3 ]
Shanahan, Catherine M. [2 ]
Zhang, Qiuping [2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610041, Sichuan, Peoples R China
[2] Kings Coll London, British Heart Fdn, Ctr Res Excellence, Cardiovasc Div, London SE5 9NU, England
[3] Univ East Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England
基金
中国国家自然科学基金;
关键词
DREIFUSS MUSCULAR-DYSTROPHY; NUCLEAR-MEMBRANE PROTEIN; KASH DOMAIN; LAMIN-A; CEREBELLAR-ATAXIA; LINC COMPLEX; ENVELOPE; MUSCLE; SYNE1; MUTATION;
D O I
10.1042/BST20180085
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nesprins (nuclear envelope spectrin repeat proteins) are a family of multi-isomeric scaffolding proteins. Nesprins form the LInker of Nucleoskeleton-and-Cytoskeleton (LINC) complex with SUN (Sad1p/UNC84) domain-containing proteins at the nuclear envelope, in association with lamin A/C and emerin, linking the nucleoskeleton to the cytoskeleton. The LINC complex serves as both a physical linker between the nuclear lamina and the cytoskeleton and a mechanosensor. The LINC complex has a broad range of functions and is involved in maintaining nuclear architecture, nuclear positioning and migration, and also modulating gene expression. Over 80 disease-related variants have been identified in SYNE-1/2 (nesprin-1/2) genes, which result in muscular or central nervous system disorders including autosomal dominant Emery-Dreifuss muscular dystrophy, dilated cardiomyopathy and autosomal recessive cerebellar ataxia type 1. To date, 17 different nesprin mouse lines have been established to mimic these nesprin-related human diseases, which have provided valuable insights into the roles of nesprin and its scaffold LINC complex in a tissue-specific manner. In this review, we summarise the existing nesprin mouse models, compare their phenotypes and discuss the potential mechanisms underlying nesprin-associated diseases.
引用
收藏
页码:669 / 681
页数:13
相关论文
共 50 条
  • [31] Humanised mouse models for haematopoiesis and infectious diseases
    Veronika, Lysenko
    Donal, McHugh
    Lena, Behrmann
    Mary-Aude, Rochat
    Christian, Wilk M.
    Larisa, Kovtonyuk
    Jean-Pierre, Bourquin
    Christian, Munz
    Markus, Manz G.
    Roberto, Speck
    Alexandre, Theocharides P. A.
    SWISS MEDICAL WEEKLY, 2017, 147
  • [32] Mouse Models as Resources for Studying Infectious Diseases
    Sarkar, Sanjay
    Heise, Mark T.
    CLINICAL THERAPEUTICS, 2019, 41 (10) : 1912 - 1922
  • [33] Criteria for Validating Mouse Models of Psychiatric Diseases
    Chadman, Kathryn K.
    Yang, Mu
    Crawley, Jacqueline N.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2009, 150B (01) : 1 - 11
  • [34] Humanized mouse models to study human diseases
    Brehm, Michael A.
    Shultz, Leonard D.
    Greiner, Dale L.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2010, 17 (02) : 120 - 125
  • [35] Mouse models as a tool for understanding neurodegenerative diseases
    Ahmad-Annuar, A
    Tabrizi, SJ
    Fisher, EMC
    CURRENT OPINION IN NEUROLOGY, 2003, 16 (04) : 451 - 458
  • [36] Transgenic Mouse Models for the Study of Neurodegenerative Diseases
    Marin-Moreno, Alba
    Canoyra, Sara
    Fernandez-Borges, Natalia
    Carlos Espinosa, Juan
    Maria Torres, Juan
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (01):
  • [37] Transgenic mouse models for the study of prion diseases
    Marin-Moreno, Alba
    Carlos Espinosa, Juan
    Maria Torres, Juan
    PRIONS AND NEURODEGENERATIVE DISEASES, 2020, 175 : 147 - 177
  • [38] Mouse Cre Models for the Study of Bone Diseases
    Dallas, Sarah L.
    Xie, Yixia
    Shiflett, Lora A.
    Ueki, Yasuyoshi
    CURRENT OSTEOPOROSIS REPORTS, 2018, 16 (04): : 466 - 477
  • [39] Genetically engineered mouse models of neurodegenerative diseases
    Wong, PC
    Cai, HB
    Borchelt, DR
    Price, DL
    NATURE NEUROSCIENCE, 2002, 5 (07) : 633 - 639
  • [40] Mouse Models of Autoimmune Diseases - Autoimmune Myocarditis
    Mueller, Anna-Maria
    Fischer, Andrea
    Katus, Hugo A.
    Kaya, Ziya
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (18) : 2498 - 2512